155 related articles for article (PubMed ID: 24984975)
1. Awash in a sea of 'bath salts': implications for biomedical research and public health.
Baumann MH
Addiction; 2014 Oct; 109(10):1577-9. PubMed ID: 24984975
[No Abstract] [Full Text] [Related]
2. Bath salts and synthetic cathinones: an emerging designer drug phenomenon.
German CL; Fleckenstein AE; Hanson GR
Life Sci; 2014 Feb; 97(1):2-8. PubMed ID: 23911668
[TBL] [Abstract][Full Text] [Related]
3. Beta-blocker use for toxicity from "bath salts".
Richards JR; Laurin EG; Albertson TE
J Emerg Med; 2015 Feb; 48(2):e45-6. PubMed ID: 25453853
[No Abstract] [Full Text] [Related]
4. Sudden cardiac death associated with methylone use.
Carbone PN; Carbone DL; Carstairs SD; Luzi SA
Am J Forensic Med Pathol; 2013 Mar; 34(1):26-8. PubMed ID: 23403480
[TBL] [Abstract][Full Text] [Related]
5. Psychoactive "bath salts": not so soothing.
Baumann MH; Partilla JS; Lehner KR
Eur J Pharmacol; 2013 Jan; 698(1-3):1-5. PubMed ID: 23178799
[TBL] [Abstract][Full Text] [Related]
6. Intranasal substituted cathinone "bath salts" psychosis potentially exacerbated by diphenhydramine.
Gunderson EW; Kirkpatrick MG; Willing LM; Holstege CP
J Addict Med; 2013; 7(3):163-8. PubMed ID: 23732955
[TBL] [Abstract][Full Text] [Related]
7. Substituted cathinone products: a new trend in "bath salts" and other designer stimulant drug use.
Gunderson EW; Kirkpatrick MG; Willing LM; Holstege CP
J Addict Med; 2013; 7(3):153-62. PubMed ID: 23732954
[TBL] [Abstract][Full Text] [Related]
8. The α- and β-Adrenergic Antagonist Controversy with Sympathomimetic Agents.
Banks ML; Worst TJ; Rusyniak DE; Sprague JE
J Emerg Med; 2015 Dec; 49(6):e209-10. PubMed ID: 26277195
[No Abstract] [Full Text] [Related]
9. The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis.
Abbott R; Smith DE
J Psychoactive Drugs; 2015; 47(5):368-71. PubMed ID: 26579784
[TBL] [Abstract][Full Text] [Related]
10. Synthetic cathinones ("bath salts").
Banks ML; Worst TJ; Rusyniak DE; Sprague JE
J Emerg Med; 2014 May; 46(5):632-42. PubMed ID: 24565885
[TBL] [Abstract][Full Text] [Related]
11. Bath Salts to Therapies: Can Separation of Adverse and Therapeutic Effects of Substituted Cathinones Lead to a Medication for Psychostimulant Use Disorder?
Unterwald EM; Rawls SM
J Pharmacol Exp Ther; 2023 Jun; 385(3):159-161. PubMed ID: 37197988
[No Abstract] [Full Text] [Related]
12. The Explosion of a New Designer Drug, Flakka: Implications for Practice.
J Addict Nurs; 2018; 29(4):E16-E17. PubMed ID: 30507827
[No Abstract] [Full Text] [Related]
13. Mephedrone related fatalities: a review.
Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3777-90. PubMed ID: 26502870
[TBL] [Abstract][Full Text] [Related]
14. Five things to know about..."bath salts".
Antoniou T; Juurlink DN
CMAJ; 2012 Oct; 184(15):1713. PubMed ID: 22908139
[No Abstract] [Full Text] [Related]
15. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2011 Oct; 76(204):65371-5. PubMed ID: 22016903
[TBL] [Abstract][Full Text] [Related]
16. Acute psychosis induced by bath salts: a case report with clinical and forensic implications.
Stoica MV; Felthous AR
J Forensic Sci; 2013 Mar; 58(2):530-3. PubMed ID: 23317451
[TBL] [Abstract][Full Text] [Related]
17. Chemokines and 'bath salts': CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats.
Oliver CF; Simmons SJ; Nayak SU; Smith GR; Reitz AB; Rawls SM
Drug Alcohol Depend; 2018 May; 186():75-79. PubMed ID: 29550625
[TBL] [Abstract][Full Text] [Related]
18. Baths salts, spice, and related designer drugs: the science behind the headlines.
Baumann MH; Solis E; Watterson LR; Marusich JA; Fantegrossi WE; Wiley JL
J Neurosci; 2014 Nov; 34(46):15150-8. PubMed ID: 25392483
[TBL] [Abstract][Full Text] [Related]
19. Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results.
Marinetti LJ; Antonides HM
J Anal Toxicol; 2013 Apr; 37(3):135-46. PubMed ID: 23361867
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetic profile of synthetic cathinones in a pregnancy model.
Strange LG; Kochelek K; Keasling R; Brown SD; Pond BB
Neurotoxicol Teratol; 2017 Sep; 63():9-13. PubMed ID: 28811141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
